793 abstracts found.



Results filter



Introduction: immunotherapy

Year:

Session type: ,


Introduction: selecting rational combinations for cancer and delivering early phase clinical trials in the UK

Year:

Session type: ,


Methodology to influence clinical practice in rare cancers

Year:

Session type: ,

Lucinda Billingham1

1Professor of Biostatistics, Director of Statistics, Cancer Research UK Clinical Trials Unit, School of Cancer Sciences and University of Birmingham


Introduction: rare tumours

Year:

Session type: ,


Introduction: microRNA and non-coding RNA

Year:

Session type: ,


The cost of cancer drugs in the US: why we must look beyond published data

Year:

Session type: ,

Tito Fojo1

1Columbia University Medical Center, New York, USA


Clash of cultures: the economic sustainability of cancer care and research across Europe

Year:

Session type: ,

Richard Sullivan1

1King’s College London, UK


Introduction: early diagnosis

Year:

Session type: ,


Introduction: advances in surgical oncology

Year:

Session type: ,


Introduction: tumour:stroma interactions

Year:

Session type: ,


Introduction: the future role of primary care in cancer control

Year:

Session type: ,


Introduction: prevention is better than cure’ – cancer chemoprevention in 2015

Year:

Session type: ,


Selective internal radiotherapy: microdosimetry, clinical research and patient advocacy

Year:

Session type: ,

Ricky Sharma1

1University of Oxford & Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, UK


Introduction: integration of germline genetic information can improve cancer diagnoses, treatment and prevention

Year:

Session type: ,


Introduction: cardiovascular toxicity in paediatric cancer treatment

Year:

Session type: ,




Introduction: molecular imaging and radionuclide therapy: The Royal College of Radiologists symposium

Year:

Session type: ,




Introduction: lifestyle behaviour and prevention

Year:

Session type: ,




Introduction: genomics and cancer evolution

Year:

Session type: ,




Introduction: DNA repair and cancer

Year:

Session type: ,


Investigating the genomic landscape of brain tumours using metabolic imaging

Year:

Session type: ,

1Kevin Brindle

1University of Cambridge, UK


Introduction: understanding the genomic landscape of brain cancer

Year:

Session type: ,


Opportunistic salpingectomy: development and implementation of an ovarian cancer prevention campaign

Year:

Session type: ,

Jessica McAlpine1

1University of British Columbia, Canada


Population-based approach(es) to genetic testing for ovarian cancer prevention

Year:

Session type: ,


Promoting physical activity among people living with advanced cancer

Year:

Session type: ,

Matthew Maddocks1

1King’s College London, UK


Reducing prostate cancer progression and mortality: what you can do to reduce your risk

Year:

Session type: ,

Stacey Kenfield1

1University of California, San Francisco & Harvard School of Public Health, Boston, USA


Introduction: physical activity – the panacea?

Year:

Session type: ,


Introduction: liquid biopsies with a twist: circulating cells and DNA

Year:

Session type: ,


Fc-mediated depletion of Tregs via ipilimumab-dependent ADCC in advanced melanoma patients

Year:

Session type: ,

Emaunela Romano1

1Institut Curie, Paris, France


BACR/AstraZeneca Young Scientist Frank Rose Award: Polyubiquitylaton drives replisome disassembly at the termination of eukaryotic DNA replication

Year:

Session type: ,

Agnieszka Gambus1

1University of Birmingham, UK


Introduction: genome instability: bench to bedside

Year:

Session type: ,


Introduction: everybody’s responsibility: systematic assessment of patient and carer needs in the oncology clinic and GP surgery

Year:

Session type: ,




Introduction: big data

Year:

Session type: ,


Introduction: e-cigarettes and policy

Year:

Session type: ,

Linda Bauld




Introduction: molecular testing for early cancer diagnosis: ready for prime time

Year:

Session type: ,




Introduction: chromatin, epigenetics and cancer

Year:

Session type: ,




The mechanistic basis of cancer immunotherapy

Year:

Session type: ,

Ira Mellman1

1Genentech, South San Francisco, USA


Lung cancer profiling: the end of the beginning

Year:

Session type: ,

Fabrice Barlesi1

1Aix Marseille University, Assistance Publique Hopitaux de Marseille, Marseille, France


NCRI and NIHR initiatives in surgical oncology. Presentation of 2015 CREST award (Cancer Research Excellence in Surgical Trials)

Year:

Session type: ,

Richard Shaw1

1NIHR Clinical Research Network: Cancer & University of Liverpool, Liverpool, UK


‘Comic opera’ is dead… surgical research is alive and well

Year:

Session type: ,

Freddie C. Hamdy1

1University of Oxford, Oxford, UK


Pitfalls in surgical trials

Year:

Session type: ,

Emiel Rutgers1

1The Netherlands Cancer Institute, Amsterdam, The Netherlands


Neutrophil-derived leukotrienes support cancer stem cells during metastasis initiation processes

Year:

Session type:

Ilaria Malanchi1

1The Francis Crick Institute, London, UK


Mobilising immunity to fight cancer

Year:

Session type:

Sergio Quezada1

1University College London Cancer Institute, London, UK


Molecular analysis of circulating tumour cells identifies distinct profiles in treatment naïve chemosensitive and chemofractory small cell lung cancer patients

Year:

Session type:

Ged Brady1

1Cancer Research Uk Manchester Institute, Manchester, UK




Benchmarking and biomarkers: the molecular and technical heterogeneity of prostate cancer

Year:

Session type: ,

Paul Boutros1

1Ontario Institute for Cancer Research, Toronto, Canada




Epigenetics impacts copy number heterogeneity and drug resistant gene selection

Year:

Session type: ,

Johnathan Whetstine1

1Harvard Medical School & Massachusetts General Hospital Cancer Center, Boston, USA




T cells and the immunogenicity of immunotherapy

Year:

Session type: ,

Adrian Hayday1

1King’s College London & The francis Crick Institute, London, UK


E-cigarettes: an evidence update

Year:

Session type: ,

Ann McNeill1

1King’s College London, London, UK


Targeting DNA repair in cancer treatment

Year:

Session type: ,

Thomas Helleday1

1Karolinska Institute, Stockholm, Sweden


Physical activity reduces late effects and improves outcomes: the clinical evidence and biological mechanisms of action

Year:

Session type:

Robert Thomas1

1Bedford & Addenbrooke’s Cambridge University Hospitals & Cranfield University, Bedford, UK


Monitoring: How should we monitor our patients for cardiovascular toxicity? Serum biomarkers, imaging or both?

Year:

Session type: ,

Charlotte Manisty1

1University College London, University College London Hospital & Barts Heart Centre, London, UK